LOMBARD MED INC's ticker is EVAR and the CUSIP is G55598109. A total of 20 filers reported holding LOMBARD MED INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $8,000 | -27.3% | 19,129 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $11,000 | -26.7% | 19,129 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $15,000 | -16.7% | 19,129 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $18,000 | -14.3% | 19,129 | 0.0% | 0.00% | -33.3% |
| Q2 2016 | $21,000 | +5.0% | 19,129 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $20,000 | -23.1% | 19,129 | 0.0% | 0.00% | -40.0% |
| Q4 2015 | $26,000 | -62.9% | 19,129 | 0.0% | 0.01% | -72.2% |
| Q3 2015 | $70,000 | -16.7% | 19,129 | 0.0% | 0.02% | +20.0% |
| Q2 2015 | $84,000 | -52.3% | 19,129 | -56.1% | 0.02% | -25.0% |
| Q1 2015 | $176,000 | -9.3% | 43,596 | +45.8% | 0.02% | -53.5% |
| Q4 2014 | $194,000 | -13.4% | 29,902 | +2.8% | 0.04% | +34.4% |
| Q3 2014 | $224,000 | +28.7% | 29,097 | +20.7% | 0.03% | +68.4% |
| Q2 2014 | $174,000 | – | 24,110 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 3,473,452 | $12,331,000 | 7.20% |
| SV Health Investors, LLC | 1,077,499 | $3,847,000 | 2.15% |
| Aisling Capital LLC | 886,363 | $3,164,000 | 0.56% |
| PURA VIDA INVESTMENTS, LLC | 52,875 | $189,000 | 0.11% |
| Verition Fund Management LLC | 19,129 | $70,000 | 0.02% |
| Weiss Multi-Strategy Advisers LLC | 97,000 | $346,000 | 0.02% |
| Spark Investment Management LLC | 26,400 | $93,000 | 0.01% |
| FIL Ltd | 786,997 | $2,865,000 | 0.01% |
| Invesco Ltd. | 6,317,851 | $22,555,000 | 0.01% |
| Alyeska Investment Group, L.P. | 167,004 | $596,000 | 0.01% |